Secondary Logo

Journal Logo

Irregular Outcomes: Predictors of New Atrial Fibrillation After Noncardiac Surgery

Nathan, Naveen MD

doi: 10.1213/ANE.0000000000002252
Infographics: Infographic
Free

Northwestern University Feinberg School of Medicine (n-nathan@northwestern.edu).

The Infographic is composed by Naveen Nathan, MD, Northwestern University Feinberg School of Medicine (n-nathan@northwestern.edu). Illustration by Naveen Nathan, MD.

An observational analysis of patients presenting for noncardiac surgery with or at risk for atherosclerotic disease found a 2.5% incidence of new, clinically significant atrial fibrillation. The authors formulated a scoring system that identified age and type of surgery as potential risk factors for the development of new atrial fibrillation.1,2

OR indicates odds ratio.

Back to Top | Article Outline

REFERENCES

1. Devereaux PJ, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839–1847.
2. Alonso-Coello P, Cook D, Xu SC, et al. Predictors, prognosis, and management of new clinically important atrial fibrillation after noncardiac surgery: a prospective cohort study. Anesth Analg. 2017;125:162–169.
Copyright © 2017 International Anesthesia Research Society